May 6, 2020
May is Maternal Mental Health Awareness Month, and today, May 6, happens to be World Maternal Mental Health Day. It’s a fitting day to bring you this show with an expert who is the driving force behind a pioneering study to help diagnose postpartum depression earlier and get moms the treatment they need.
Dr. Samantha Meltzer-Brody, MD, MPH, is co-principal investigator of the Mom Genes Fight PPD research study, as well as the Assad Meymandi Distinguished Professor and Chair of the UNC Department of Psychiatry and director of the UNC Center for Women’s Mood Disorders. Her funded research is focused on understanding the genetic signature of postpartum depression and investigating novel technologies and treatment modalities to optimize and personalize treatment for women with perinatal depression. Most recently, this has included the MOM GENES app and the brexanolone clinical trials, the first FDA-approved medication for postpartum depression. She knows a lot, and she’s done a lot with her significant work in perinatal mental health.
Mom Genes Fight PPD Learn how you can join the study from the comfort of your own home.